Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Razani

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Physiology & Behavior|April 1, 1996
Odor sensitivity is impaired in HIV-positive cognitively impaired patientsJ Razani, C Murphy, T M Davidson, et al.
Journal of the International Neuropsychological Society : JINS|June 9, 2001
Neuropsychological performance of right- and left-frontotemporal dementia compared to Alzheimer's diseaseJ Razani, K B Boone, B L Miller, et al.
International Pharmacopsychiatry|January 1, 1981
Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics. A comparative study of haloperidol versus mesoridazineK White, J Busk, E Eaton, et al.
Psychological Medicine|August 1, 1983
Relapse in schizophrenia: a review of the concept and its definitionsI R Falloon, G N Marshall, J L Boyd, et al.
Comprehensive Psychiatry|September 1, 1983
Platelet MAO activity in depressionK White, N Macdonald, J Razani, et al.
Psychopharmacology Bulletin|October 1, 1982
Combined MAOI-tricylic antidepressant treatment: a controlled trialK White, J Razani, G Simpson, et al.
Psychopharmacology|January 1, 1984
Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trialK White, J Razani, B Cadow, et al.
Archives of General Psychiatry|June 1, 1983
The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trialJ Razani, K L White, J White, et al.
The New England Journal of Medicine|June 17, 1982
Family management in the prevention of exacerbations of schizophrenia: a controlled studyI R Falloon, J L Boyd, C W McGill, et al.
Archives of General Psychiatry|September 1, 1985
Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal studyI R Falloon, J L Boyd, C W McGill, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Physiology & Behavior|April 1, 1996
Odor sensitivity is impaired in HIV-positive cognitively impaired patientsJ Razani, C Murphy, T M Davidson, et al.
Journal of the International Neuropsychological Society : JINS|June 9, 2001
Neuropsychological performance of right- and left-frontotemporal dementia compared to Alzheimer's diseaseJ Razani, K B Boone, B L Miller, et al.
International Pharmacopsychiatry|January 1, 1981
Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics. A comparative study of haloperidol versus mesoridazineK White, J Busk, E Eaton, et al.
Psychological Medicine|August 1, 1983
Relapse in schizophrenia: a review of the concept and its definitionsI R Falloon, G N Marshall, J L Boyd, et al.
Comprehensive Psychiatry|September 1, 1983
Platelet MAO activity in depressionK White, N Macdonald, J Razani, et al.
Psychopharmacology Bulletin|October 1, 1982
Combined MAOI-tricylic antidepressant treatment: a controlled trialK White, J Razani, G Simpson, et al.
Psychopharmacology|January 1, 1984
Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trialK White, J Razani, B Cadow, et al.
Archives of General Psychiatry|June 1, 1983
The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trialJ Razani, K L White, J White, et al.
The New England Journal of Medicine|June 17, 1982
Family management in the prevention of exacerbations of schizophrenia: a controlled studyI R Falloon, J L Boyd, C W McGill, et al.
Archives of General Psychiatry|September 1, 1985
Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal studyI R Falloon, J L Boyd, C W McGill, et al.
Pageof 3